Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

MagBio Launches its Novel cfKapture 21 Kit

MagBio Genomics announces the launch of its new cfKapture 21 kit. cfKapture 21 kit is said to be a novel solution for isolation of circulating Cell-Free DNA (ccfDNA) from stabilized plasma sample.

cfKapture 21 system is a ccfDNA isolation kit which includes a proprietary reagent that prevents post-separation degradation of plasma and ccfDNA fragments for up to 21 days at room temperature.

Laboratories can easily and safely transport process samples within a much longer time frame without the requirement for extensive cold chain through this feature. It also reduces cost, enhances efficiency, and also increases outreach for both local and international samples.

cfKapture 21 is the only kit on the market able to provide this level of flexibility for processing plasma samples in a high throughput setting.

It is compatible with any whole blood collection tube. In addition, it can be used in combination with the MagBio Blood STASIS 21-ccfDNA tube to ensure recovery of the maximum quality ccfDNA appropriate for most liquid biopsy applications.

Blood STASIS 21-ccfDNA is a direct draw whole blood collection system with a proprietary blood stabilization reagent, compatible with almost all liquid biopsy applications for cancer genomic research and Non-invasive Prenatal testing (NIPT).

The MagBio cfKapture 21 kit offers a cost effective solution to blood sampling and ccdDNA isolation using MagBio's Blood STASIS 21- ccfDNA tube.

In order to maintain the integrity of ccfDNA within the samples they have to be shipped frozen with dry ice for the duration of the transport cycle. The samples of plasma are used for ccfDNA.

Because stabilizing plasma samples during transport remains a major hurdle in obtaining meaningful data from ccfDNA, MagBio developed the cfKapture 21 purification kit to overcome this challenge.

The MagBio cfKapture 21 kit includes a reagent that allows short-term transport and storage of separated plasma at room temperature for 21 days while maintaining the stability of ccfDNA.  

As it contains the unique feature, cfKapture21 provides flexibility in plasma sample processing as well as significant cost savings associated with sample handling in both manual and automated ccfDNA isolation settings.

magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinRehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024